Soo Youn Chung

Korea Institute of Drug Safety & Risk Management, Republic of Korea

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Poster(s):

• (P-294) Risk of Fracture Associated with SGLT-2 Inhibitors as an Add-on Therapy to Metformin in Patients with Type 2 Diabetes Mellitus

• (P-323) Risk of Cardiovascular Diseases Associated with Sulfonylurea as an Add-on Therapy to Metformin in Patients with Type 2 Diabetes Mellitus